Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 245,440 | 306,763 | 178,800 | 284,466 | 259,496 |
| Receivables | 216,855 | 202,657 | 206,562 | 179,142 | 159,376 |
| Inventories | 306,370 | 365,141 | 317,202 | 259,379 | 293,027 |
| TOTAL | $834,879 | $934,975 | $768,903 | $769,722 | $756,031 |
| Non-Current Assets | |||||
| PPE Net | 305,761 | 284,052 | 311,362 | 310,885 | 258,482 |
| Intangibles | 1,104,023 | 1,060,012 | 971,199 | 742,002 | 777,548 |
| Other Non-Current Assets | 151,262 | 171,909 | 144,127 | 112,216 | 67,673 |
| TOTAL | $1,561,046 | $1,515,973 | $1,426,688 | $1,165,103 | $1,103,703 |
| Total Assets | $2,395,925 | $2,450,948 | $2,195,591 | $1,934,825 | $1,859,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,056 | 66,999 | 73,358 | 63,929 | 58,371 |
| Accrued Expenses | 68,191 | 59,423 | 80,708 | 64,475 | 48,540 |
| Other current liabilities | 158,337 | 148,133 | 136,088 | 111,628 | 121,207 |
| TOTAL | $282,599 | $578,113 | $300,383 | $251,816 | $442,266 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,219,565 | 921,230 | 797,564 | 754,102 | 559,441 |
| Other Non-Current Liabilities | 59,393 | 68,194 | 75,041 | 74,715 | 79,876 |
| TOTAL | $1,317,006 | $1,051,999 | $935,249 | $865,012 | $668,044 |
| Total Liabilities | $1,599,605 | $1,630,112 | $1,235,632 | $1,116,828 | $1,110,310 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,446 | 48,037 | 50,841 | 50,541 | 51,277 |
| Common Shares | 453 | 482 | 508 | 504 | 511 |
| Retained earnings | 279,344 | 352,174 | 360,456 | 253,168 | 202,391 |
| Other shareholders' equity | -37,614 | -55,084 | -35,632 | -30,381 | -25,954 |
| TOTAL | $796,320 | $820,836 | $959,959 | $817,997 | $749,424 |
| Total Liabilities And Equity | $2,395,925 | $2,450,948 | $2,195,591 | $1,934,825 | $1,859,734 |